Could this non-invasive device relieve your treatment-resistant pain?
Watch the variation of green (560nm) through yellow (600nm) wavelengths of the light being applied to a leg wound via PhotoMed’s Vari-Chrome® Pro. The operator now has access to the entire visible spectrum, with no missing wavelengths.
Have you ever seen fresh exudates enter a wound? (Warning: link presents close-up graphic images of wounds)
What’s new in the delivery of light in medicine?
150 years ago, red light was found to relieve musculoskeletal pain and impairments.
In 1903, Dr. Finsen was awarded a Nobel Prize for Medicine. External Link (1)
He found blue wavelengths to stimulate nerves.
Patients and operators of the Vari-Chrome® Pro can quickly find out if any visible wavelengths might work.
How could a few photons prompt the body to do what it had been trying to - for years?
As nerdy engineers, we don’t have a clue. Neither do our advisory anesthesiologists or neurologists.
Is it neuroplasticity? Quantum entanglement? Or, your best guess?
Additional topics are available through the navigation bar.
Could 1 wavelength be “best” for all disorders?
Red and blue address different disorders that may be responsive to those wavelengths.
PhotoMed’s team wondered, could 1, 2, or a sequence of wavelengths be needed to relieve treatment-resistant pain?
PhotoMed’s skeptical team did what Silicon Valley software engineers do. They developed data-centric tools to find out. They thought that by-the-second data might show that something special was going on.
Real-time recordings from PhotoMed’s Instant Verification System™ blew past everyone’s imagination.
Could skin temperatures tell a story?
“Robert’s” hands had felt uncomfortably cold for 30 years. His co-workers complained that he liked the room too warm for their comfort. His hands warmed to the first test of PhotoMed’s therapy during each of 3 visits. His hands normalized. His co-workers were pleased.
Could the therapy help everyone?
500+ people with treatment-resistant pain or impaired functions volunteered in studies to find out. Many arrived with multiple disorders. The disorders could respond independently with improved function and pain relief, or not.
The studies included nearly everyone despite having no expectation of improvement. It took years to fail in only 2 out of 3 cases.
Patients in 1 of 3 cases reported significant improvement.
We’re still trying to reduce the failure rate below 2 out of 3 cases of treatment-resistant pain or impairments.
When will it work?
As software engineers, we do not get why you must wait so long for outcomes.
Success in PhotoMed’s studies was judged by when a physiological response marks improving impaired functions.
In about 2 minutes, you can typically observe a physiological response, or not, to each procedure. That’s 1000x faster than conventional testing of medications, but with the same logic.
That efficiency translates to needing only 2 visits with no response to detect probable failure for that disorder. Of course, some disorders take a bit longer, such as inflammation, to detect failure.
Did the therapy work? If yes, then additional visits may be needed for the body to finish its healing tasks.
Vari-Chrome® Pro operators will be brought up to speed on how to use PhotoMed’s Triple 2 Algorithm. The algorithm also lets you know when it might be time to quit.
Could it really be the “back-to-normal function”?
The physiological responses appeared to be too fast and too large. Textbooks couldn’t help for they only told why the pain was expected to remain.
It took 18-years of examining PhotoMed’s recorded data to satisfy the nerdy skeptics that the responses appear to be entirely ordinary. Because improved functions persist after therapy ends, some call that homeostasis. For bio-mechanical reasons, normal isn’t perfect. What do you think?
Or as your grandmother might say, it was just going “back-to-normal”.
(1) Niels Ryberg Finsen, The Nobel Prize in Physiology or Medicine 1903 https://www.nobelprize.org/prizes/medicine/1903/finsen/biographical/
(2) Jedlicka P. Revisiting the Quantum Brain Hypothesis: Toward Quantum (Neuro)biology?. Front Mol Neurosci. 2017;10:366. Published 2017 Nov 7. doi:10.3389/fnmol.2017.00366 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681944/